However the ability of CCL2, CXCL1, CXCL5 and VEGF to significantly reduce IL-12p70 production by DCs is important, as this may potentially result in a reduced anti-tumour Th1 response in vivo. This evidence concerns the gene CCL2 and neoplasm.